Tulabing, Analyn .

HRN: 28-47-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/06/2026
03/13/2026
IV
1g
Ptor
D& C
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines